MA5-14820
antibody from Invitrogen Antibodies
Targeting: DNAJC3
ERdj6, HP58, P58, p58(IPK), P58IPK, PRKRI
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-14820 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- DNAJC3 Monoclonal Antibody (J.98.6)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide
- Description
- It is not recommended to aliquot this antibody.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Isotype
- IgG
- Antibody clone number
- J.98.6
- Vial size
- 100 µL
- Concentration
- 154 µg/mL
- Storage
- -20°C
Submitted references Inhibition of eIF2α Dephosphorylation Protects Hepatocytes from Apoptosis by Alleviating ER Stress in Acute Liver Injury.
Inhibiting alpha subunit of eukaryotic initiation factor 2 dephosphorylation protects injured hepatocytes and reduces hepatocyte proliferation in acute liver injury.
Tang YJ, Chen H, Yi Y, Chen GM, Yang FW, Li Y, Tian RD, Huang WG, Cheng QJ, He YH
BioMed research international 2020;2020:2626090
BioMed research international 2020;2020:2626090
Inhibiting alpha subunit of eukaryotic initiation factor 2 dephosphorylation protects injured hepatocytes and reduces hepatocyte proliferation in acute liver injury.
Chen G, Yang X, He Y, Tang Y, Tian R, Huang W, Chen H, Yang F, Li Y, Lin S
Croatian medical journal 2019 Dec 31;60(6):532-544
Croatian medical journal 2019 Dec 31;60(6):532-544
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 3 The inhibition of alpha subunit of eukaryotic initiation factor 2 (eIF2alpha) dephosphorylation mitigates carbon tetrachloride (CCl 4 )-induced hepatocyte proliferation in mice. Male BALB/c mice were pretreated with vehicle (dimethyl sulfoxide + phosphate buffer solution), salubrinal, integrated stress response inhibitor (ISRIB) for 2 h, or recombinant AAV8 expressing DnaJC3 for 4 weeks, then injected with olive oil or CCl 4 . Relative levels of intrahepatic cyclin D1 and proliferating cell nuclear antigen (PCNA) expression at 24 h after CCl 4 injection were determined by Western blot. PCNA expression was assessed by immunohistochemistry. ( A ) Salubrinal, ISRIB, or overexpressed DnaJC3 altered eIF2alpha phosphorylation, DnaJC3, and PCNA expression (n = 6; total mice = 30). ( B ) Salubrinal, ISRIB, or ( C ) overexpressed DnaJC3 altered the levels of CCl 4 -induced eIF2alpha phosphorylation, cyclin D1, and PCNA expression (n = 8, total mice = 40, day 1). ( D ) Immunohistochemistry analysis of hepatic PCNA expression (magnification x100).